CV6 Therapeutics Named Team of the Year at Belfast Chamber Business Awards

CV6 Therapeutics named Team of the Year at Belfast Chamber Business Awards

CV6 Therapeutics was named Team of the Year at the 2026 Belfast Chamber Business Awards, held in partnership with Bank of Ireland. The awards were presented at a black-tie gala at ICC Belfast, attended by more than 600 guests.

CV6 was also Highly Commended in the Business Innovation category, sponsored by Kingsbridge Healthcare Group. The Team of the Year award was sponsored by Cathedral Quarter BID.

CV6 was the only biotech among the Team of the Year finalists. The other finalists were Airbus Belfast 350F Engineering Team, Cathedral Eye Clinic and Cathedral Dermatology Clinic, HireIQ, Huron Consulting Group, Ionic Technologies and Queen’s Business School Careers.

In a LinkedIn post after the ceremony, CV6 CEO Dr Robert “Bob” Ladner credited the wider group behind the company’s work:

“This recognition belongs to our scientists; our leadership, operational, legal, and communications colleagues; the clinicians and trial teams caring for patients across the UK; our Board; our scientific and medical advisors; our investors and supporters; and everyone who has helped move CV6-168 from laboratory research into patients. I am extremely proud of this team.”

Dr Robert “Bob” Ladner, in a LinkedIn post

CV6-168, the company’s first-in-class investigational oncology medicine, is nearing completion of Phase 1a clinical trials. CV6’s Belfast team is based at the Johnston Cancer Research Centre at Queen’s University Belfast. CV6 is a QUBIS portfolio company.

CV6 also congratulates Dr Len O’Hagan, Pro-Chancellor and Chair of Senate at Queen’s University Belfast, on receiving the Lifetime Achievement Award.

The company congratulates all the finalists and winners recognised at the ceremony, and the wider Belfast workforce it is proud to be part of.